期刊
MOLECULAR MEDICINE REPORTS
卷 16, 期 3, 页码 3117-3124出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2017.6984
关键词
lipo-PGE(1); angiogenesis; vascular endothelial growth factor; vascular endothelial growth factor receptor antagonist; cognitive impairment
资金
- Science and Technology Bureau Foundation of Guangzhou [2014J4100077]
- Medical Science and Technology Research Foundation of Guangdong [B2016018]
The pathological mechanism of vascular cognitive impairment (VCI) involves ischemic lesions in the hippocampus. Prostaglandin E-1 (PGE(1)) serves roles in the promotion of vascular endothelial growth factor (VEGF) expression, angiogenesis and enhances blood flow to ischemic regions. However, the effect of PGE(1) on cognitive function in VCI rats and the underlying mechanism are unknown. In the current study, learning and memory function in VCI rats treated by lipo-PGE(1) injection was assessed through Morris Water Maze test. Furthermore, the histological alterations, blood vessel numbers in the hippocampal CA(1) region and relative VEGF protein and mRNA expression were researched. The results confirmed that VCI rats treated with lipo-PGE(1) presented improved cognitive function, less neuronal cell loss, a greater number of blood vessels in the hippocampal region and higher VEGF protein and mRNA expression. However, the role of lipo-PGE(1) in VCI rats can be inhibited by SU5416 (a specific VEGFR2 antagonist). The results indicated that lipo-PGE(1) may alleviate cognitive deficits in VCI rats. The underlying mechanism may be associated with angiogenesis promoted by lipo-PGE(1), which may involve the VEGF/VEGFR pathway. These findings may have therapeutic implications for cognitive impairment induced by hypoperfusion or chronic ischemic lesions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据